Humacyte, Inc. Announces Pricing of Public Offering of Common Stock
Humacyte intends to use the net proceeds that it will receive from the offering to fund the commercialization of SYMVESS™ in the vascular trauma indication, the development of the product candidates ...
After rough homestand, Devils aim for more consistency at Chicago
The New Jersey Devils have occupied third place in the Metropolitan Division for more than two months and hold a seven-point edge on the New York Islanders and New York Rangers with 10 games remaining ...
Qifu Technology, Inc. Announces Pricing of Offering of US$600 Million Cash-par Settled Convertible Senior Notes
Qifu Technology, Inc. (NASDAQ: QFIN; HKEx: 3660) (“Qifu Technology” or the “Company”), a leading AI-empowered Credit-Tech platform in China, today announced the pricing of its previously announced ...